CN102631586A - Medicinal moxibustion preparation for treating myopia and amblyopia - Google Patents
Medicinal moxibustion preparation for treating myopia and amblyopia Download PDFInfo
- Publication number
- CN102631586A CN102631586A CN2012101511950A CN201210151195A CN102631586A CN 102631586 A CN102631586 A CN 102631586A CN 2012101511950 A CN2012101511950 A CN 2012101511950A CN 201210151195 A CN201210151195 A CN 201210151195A CN 102631586 A CN102631586 A CN 102631586A
- Authority
- CN
- China
- Prior art keywords
- preparation
- moxibustion
- treatment
- herba
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a medicinal moxibustion preparation for treating myopia and amblyopia. The preparation is prepared by the following steps: twisting mugwort, bamboo shavings, eclipta alba, selfheal, mulberry leaf and longhairy antenoron herb into fleece state; crushing mint, oriental wormwood, tribulus terrestris L, immature bitter orange, frankincense and myrrh into fine powder; uniformly mixing the fine powder and fleece; and smashing the fleece into a medicinal moxibustion strip. The prescription is a pure Chinese medicinal preparation, directly acts to eyes through a pyretic moxibustion therapy, and has the function of treating both principle and secondary aspect of a disease, exact curative effect, small toxic or side effect and safety and reliability, so that the clinical symptom quickly disappears, and the disease does not relapse after being healed. The preparation can be used in treatment of myopia and amblyopia of adolescents and children effectively, safely and widely.
Description
Technical field
The present invention provides a kind of medicine moxibustion preparation of treating near-sighted amblyopia, through hot moxibustion therapy treatment ophthalmic diseases, belongs to the Chinese medicine and pharmacy technical field.
Background technology
At present, amblyopia, myopia are the modal diseases of adolescence, and this disease sickness rate is high, account for the 2--3% of teenager toatl proportion.Because adolescence is the growth critical period of vision, these oculopathy that adolescence takes place are grown very harmful to the teenager vision, if many ocular disease can not cure at adolescence, with the lifelong disability that causes eyes.Traditional treatment Chinese and western drugs and instrument have a lot, but most of effect is unsatisfactory, even certain curative effect is arranged, phenomenon also often has a rebound.
Summary of the invention
The present invention provides a kind of medicine moxibustion preparation of treating near-sighted amblyopia, has broken through doctor trained in Western medicine " instant effect does not effect a permanent cure " and the drawback of the traditional Chinese medical science " effect a permanent cure but take effect slow ".
The medicine moxibustion preparation of the near-sighted amblyopia of treatment disclosed by the invention is characterized in that being processed by ratio of weight and the number of copies by following medicine:
Folium Artemisiae Argyi 30 ~ 40, Caulis Bambusae In Taenia 15 ~ 20, Herba Ecliptae 15 ~ 20, Fructus Aurantii Immaturus 20 ~ 25, Olibanum 10 ~ 15, Myrrha 10 ~ 15, Spica Prunellae 15 ~ 20, Folium Mori 15 ~ 20, Herba Lysimachiae 15 ~ 20, Herba Menthae 15 ~ 20, Artemisia anethoicles Mattf 15 ~ 20, Fructus Atriplicis Sibiricae 15 ~ 20.
Preferred prescription of the present invention is:
Folium Artemisiae Argyi 30, Caulis Bambusae In Taenia 15, Herba Ecliptae 15, Fructus Aurantii Immaturus 20, Olibanum 10, Myrrha 10, Spica Prunellae 15, Folium Mori 15, Herba Lysimachiae 15, Herba Menthae 15, Artemisia anethoicles Mattf 15, Fructus Atriplicis Sibiricae 15.
The preparation technology of pharmaceutical preparation of the present invention is following:
Folium Artemisiae Argyi, Caulis Bambusae In Taenia, Herba Ecliptae, Spica Prunellae, Folium Mori, Herba Lysimachiae are twisted with the fingers into velvet-like, Herba Menthae, Artemisia anethoicles Mattf, Fructus Atriplicis Sibiricae, Fructus Aurantii Immaturus, Olibanum, Myrrha are ground into fine powder,, smash floss and process medicine moxibustion bar and get final product fine powder and floss mix homogeneously.
Usage and dosage:To enclose the acupuncture point near the eyes is main.The patient gets seat or clinostatism, medicine moxibustion of the present invention is placed on eye warming moxibustion apparatus the inside lights, and in eye peripheral point medicine moxibustion back and forth, ownly feels slight fever or surrounding skin flushing, medicine moxibustion Jingming, Yuyao, GB1, Sibai then, every cave medicine moxibustion 5-10 minute.Medicine moxibustion every day once, 10 days is a course of treatment.Have three days off after one course of treatment, continue the treatment of the next course of treatment again, vision can be significantly improved after two courses of treatment.
The side separates:In the medicine of the present invention, Folium Artemisiae Argyi is a monarch drug, dispelling cold and removing dampness, warming the meridian for stopping bleeding.Caulis Bambusae In Taenia: removing heat-phlegm, relieve restlessness and prevent vomiting.Be used for the gallbladder fire and hold expectorant under the arm, the dysphoria with smothery sensation vomiting, eye is lost in palpitation with fear; Herba Ecliptae: nourishing the liver and kidney, cooling blood for hemostasis.Fructus Aurantii Immaturus: stop in stagnant; The feeling of fullness distending pain.Olibanum: go into the heart, liver, spleen channel; Regulating qi and activating blood, analgesic therapy chases after poison, controls coagulation of QI-blood; Myrrha: conjunctival congestion and swelling pain, promoting blood circulation and stopping pain, detumescence and promoting granulation; Folium Mori: have effects such as blood pressure lowering, blood fat, antiinflammatory; Herba Lysimachiae: have heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, the effect of dampness removing jaundice eliminating; Herba Menthae: relieving fever with drugs of pungent flavor and cool nature, control diseases such as headache, conjunctival congestion; Artemisia anethoicles Mattf: the raw pathogenic heat gas of main air, accumulation of heat jaundice and blood pressure lowering; Fructus Atriplicis Sibiricae: suppressing the hyperactive liver resolving depression, dispelling pathogenic wind for improving eyesight; Spica Prunellae: order pearl nyctalgia, photophobia are shed tears, the vertigo.The collaborative compatibility of all medicines, according to the hot moxibustion mechanism of action, through the medicine moxibustion in combustion process; The heat effect that produces will be delivered to the channel system of eye, the immunity and the self-regulating function of transfer human body at the drug effect of medicine; Working in coordination with each other under the effect that excites each other, produce the multiple effect in the treatment.
The principle of medicine moxibustion treatment vision of the present invention is: the medicine moxibustion has penetration through the infrared biological mixing energy of special distance that burning discharges, and increases the eye microcirculation, improves tissue and supports, and thoroughly repairs damaged cell, recovers refractive power, realizes basic treatment myopia; Activate neurocyte, excited pathways for vision, two-way activation meridians, excited pathways for vision.Activation of mitochondria is supplied with eye cytotrophy ability, repairs impaired optic cell, and diseased cells is converted into normal cell, and myopia, amblyopia are treated long-term stability from this.
Treat case with medicine of the present invention and reached 110 many cases, determined curative effect, that wherein cures fully accounts for 60.0%, and that cures basically accounts for 29.1%, and total effective rate reaches 89.1%.
Good effect of the present invention is:Prescription is a pure Chinese medicinal preparation, through hot moxibustion therapy, directly acts on eye; Function with treating both the principal and secondary aspects of a disease, determined curative effect, toxic and side effects is little; Safe and reliable; Clinical symptom disappearance is rapid, cures the back disease and does not have bounce-back, can begin effectively, safely, be widely used for the treatment of youngsters and children amblyopia, myopia.
The specific embodiment
Embodiment 1
Twist with the fingers into Folium Artemisiae Argyi 30g, Caulis Bambusae In Taenia 15g, Herba Ecliptae 15g, Spica Prunellae 15 g, Folium Mori 15g, Herba Lysimachiae 15g velvet-like; Herba Menthae 15g, Artemisia anethoicles Mattf 15g, Fructus Atriplicis Sibiricae 15g, Fructus Aurantii Immaturus 20g, Olibanum 10g, Myrrha 10g are ground into fine powder; With fine powder and floss mix homogeneously, smash floss and process the smoked moxibustion of moxa roll and process the moxibustion of column medicine and get final product.
Embodiment 2
Twist with the fingers into Folium Artemisiae Argyi 40g, Caulis Bambusae In Taenia 20g, Herba Ecliptae 20g, Spica Prunellae 20g, Folium Mori 20g, Herba Lysimachiae 20g velvet-like; Herba Menthae 20g, Artemisia anethoicles Mattf 20g, Fructus Atriplicis Sibiricae 20g, Fructus Aurantii Immaturus 25g, Olibanum 15g, Myrrha 15g are ground into fine powder; With fine powder and floss mix homogeneously, smash floss and process the smoked moxibustion of moxa roll and process the moxibustion of column medicine and get final product.
Embodiment 3
Twist with the fingers into Folium Artemisiae Argyi 35g, Caulis Bambusae In Taenia 18g, Herba Ecliptae 18g, Spica Prunellae 18g, Folium Mori 18g, Herba Lysimachiae 18g velvet-like; Herba Menthae 18g, Artemisia anethoicles Mattf 18g, Fructus Atriplicis Sibiricae 18g, Fructus Aurantii Immaturus 22g, Olibanum 18g, Myrrha 18g are ground into fine powder; With fine powder and floss mix homogeneously, smash floss and process the smoked moxibustion of moxa roll and process the moxibustion of column medicine and get final product.
Select part to cure the curative effect of case history below
with explanation medicine of the present invention.
Case 1
The Wang, the woman, 11 years old, to find to be sitting in recently second row and look at the blackboard unclearly, the dream at night is waken up, and school grade descends, the R--0.6 that tests eyesight, L--0.5.The eye position, ocular movemeut, external eyes are all normal; Examination of ocular fundus: papilla of optic nerve temporo side crescent shape conus is surplus normal.Diagnosis: myopia.Adopt medicine moxibustion Therapeutic Method of the present invention, medicine moxibustion every day once, 10 days is a course of treatment.Have three days off after one course of treatment, continue the treatment of the next course of treatment again, vision can be significantly improved after two courses of treatment.
Case 2
Lee, man, 8 years old.It is unclear to find to look at the blackboard class hour on the infant, the close 1 year of writing, read a book.Test eyesight: R--0.3, L--0.3.Wear the mirror binocular vision and reach 1.0.Diagnosis: myopia.Adopt medicine moxibustion of the present invention treatment, medicine moxibustion every day once, 10 days is a course of treatment.Vision can be significantly improved after 4 courses of treatment.Patient's vision is stabilized in 1.0, follows up a case by regular visits to 3 years, and infant keeps good vision always.
Case 3
Grandson, woman, 7 years old.Find hypermetropia, amblyopia during school health check-up in 2006.Adopt medicine moxibustion of the present invention treatment, medicine moxibustion every day once, 10 days is a course of treatment, vision can be significantly improved after three courses of treatment.Vision rises to 0.8 by original 0.1, after after treatment 15 days returns to twenty-twenty vision 1.2 fully.Followed up a case by regular visits to 2 years, it is good that vision keeps.
Case 4
Lee, woman 18 years old comes my institute's treatment because of suffering from myopia, adopts medicine moxibustion Therapeutic Method of the present invention, medicine moxibustion every day once, 10 days is a course of treatment, vision can be significantly improved after four courses of treatment.The contrast of vision before and after the treatment: right eye 0.1 before the treatment, left eye 0.2, treatment back right eye returns to 1.0, and left eye returns to 1.2.
Case 5
Prunus mume (sieb.) sieb.et zucc., woman 24 years old, with blurring of vision, visual deterioration was chief complaint institute in 2 years.The right eye 0.1 that has an eyesight test, the left eye 0.08. right eye 0.5 of correcting defects of vision, about 0.4.Adopt medicine moxibustion Therapeutic Method of the present invention, medicine moxibustion every day once, 10 days is a course of treatment.Vision can be significantly improved after four courses of treatment, and treatment back right eye returns to 1.0, and left eye returns to 1.0.
Case 6
Liu, the man, 18 years old, eyes blurring of vision 3 years increased the weight of to satisfy me in the recent period and institute goes to a doctor.The eyes of testing eyesight are 0.2, correct defects of vision 0.6.Adopt medicine moxibustion Therapeutic Method of the present invention, medicine moxibustion every day once, 10 days is a course of treatment.Have three days off after one course of treatment, continue the treatment of the next course of treatment again, vision can be significantly improved after five courses of treatment; Treatment back right eye returns to 0.8, and left eye returns to 1.2.
Claims (3)
1. medicine moxibustion preparation of treating ophthalmic diseases is characterized in that being processed by ratio of weight and the number of copies by following medicine:
Folium Artemisiae Argyi 30 ~ 40, Caulis Bambusae In Taenia 15 ~ 20, Herba Ecliptae 15 ~ 20, Fructus Aurantii Immaturus 20 ~ 25, Olibanum 10 ~ 15, Myrrha 10 ~ 15, Spica Prunellae 15 ~ 20, Folium Mori 15 ~ 20, Herba Lysimachiae 15 ~ 20, Herba Menthae 15 ~ 20, Artemisia anethoicles Mattf 15 ~ 20, Fructus Atriplicis Sibiricae 15 ~ 20.
2. the medicine moxibustion preparation of the described treatment ophthalmic diseases of claim 1 is characterized in that being processed by ratio of weight and the number of copies by following medicine:
Folium Artemisiae Argyi 30g, Caulis Bambusae In Taenia 15g, Herba Ecliptae 15g, Fructus Aurantii Immaturus 20g, Olibanum 10g, Myrrha 10g, Spica Prunellae 15g, Folium Mori 15g, Herba Lysimachiae 15g, Herba Menthae 15g, Artemisia anethoicles Mattf 15g, Fructus Atriplicis Sibiricae 15g.
3. the method for preparing of medicine moxibustion preparation of treating ophthalmic diseases according to claim 1 or claim 2 is following:
Folium Artemisiae Argyi, Caulis Bambusae In Taenia, Herba Ecliptae, Spica Prunellae, Folium Mori, Herba Lysimachiae are twisted with the fingers into velvet-like, Herba Menthae, Artemisia anethoicles Mattf, Fructus Atriplicis Sibiricae, Fructus Aurantii Immaturus, Olibanum, Myrrha are ground into fine powder,, smash floss and process Moxibustion strip and get final product fine powder and floss mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101511950A CN102631586B (en) | 2012-05-16 | 2012-05-16 | Medicinal moxibustion preparation for treating myopia and amblyopia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101511950A CN102631586B (en) | 2012-05-16 | 2012-05-16 | Medicinal moxibustion preparation for treating myopia and amblyopia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102631586A true CN102631586A (en) | 2012-08-15 |
| CN102631586B CN102631586B (en) | 2013-11-20 |
Family
ID=46616268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101511950A Expired - Fee Related CN102631586B (en) | 2012-05-16 | 2012-05-16 | Medicinal moxibustion preparation for treating myopia and amblyopia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102631586B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435052A (en) * | 2015-12-24 | 2016-03-30 | 薛学明 | Medicine for treating myopic amblyopia and preparation method of medicine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1130517A (en) * | 1995-03-08 | 1996-09-11 | 胡慧 | Medicine for treating youngsters' myopia |
-
2012
- 2012-05-16 CN CN2012101511950A patent/CN102631586B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1130517A (en) * | 1995-03-08 | 1996-09-11 | 胡慧 | Medicine for treating youngsters' myopia |
Non-Patent Citations (4)
| Title |
|---|
| 《中国针灸辞典》 20021231 高希言主编 艾条 河南科学技术出版社 第3页 1-3 , * |
| 《北京中医药大学硕士学位论文》 20081231 张颖 中国中医科学院眼科用药规律探讨 13－17页，49－50页 1-3 , * |
| 张颖: "中国中医科学院眼科用药规律探讨", 《北京中医药大学硕士学位论文》 * |
| 高希言主编: "《中国针灸辞典》", 31 December 2002, 河南科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435052A (en) * | 2015-12-24 | 2016-03-30 | 薛学明 | Medicine for treating myopic amblyopia and preparation method of medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102631586B (en) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103083609B (en) | Traditional Chinese medicine for treating cervical spondylosis, lumbar intervertebral disc herniation and ankylosing spondylitis | |
| CN101524513A (en) | Health pillow drug core | |
| CN105168984A (en) | Chinese herbal compound eye plaster for treating ophthalmic diseases | |
| CN100534509C (en) | Chinese-medicinal suppository for treating lumbar vertebrae disease and preparation method thereof | |
| CN103316315B (en) | Cooling paste | |
| CN104306592A (en) | Plaster for treating cervical spondylosis and preparation method thereof | |
| CN102631586B (en) | Medicinal moxibustion preparation for treating myopia and amblyopia | |
| CN103446386B (en) | A kind of Chinese medicine composition for the treatment of lumbago | |
| CN115350260A (en) | Daily care biological agent with sleep-aiding function for skin and preparation method thereof | |
| CN101843815A (en) | Medicated wine | |
| CN100998660B (en) | Traditional Chinese medicine plaster for treating vertebral artery type cervical spondylosis and its preparing method | |
| CN103381223A (en) | Medicament for treating epilepsy | |
| CN104435582A (en) | Traditional Chinese medicine plaster for treating depression and insomnia of middle-aged and old people | |
| CN1895633A (en) | Chinese-medicinal suppository for treating cervical spondylosis and its preparation | |
| CN106138989A (en) | One treats the puckery presbyopic medicine moxibustion preparation of an xerophthalmia | |
| CN104398712A (en) | Chinese medicinal preparation for treating facial spasm and preparation method | |
| CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
| CN102579757B (en) | Anti-aging Chinese medicine composition in separation medicine and moxibustion umbilicus mode | |
| CN101579419B (en) | Medicinal liquor for treating hyperosteogeny | |
| CN100563674C (en) | Double sticking double effect plaster by internal and external combined treatment | |
| CN102920782B (en) | Medicine for treating cervical spondylosis and lumbar spondylosis | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN101229356B (en) | External wad for treating cervical spondylosis | |
| CN104873668A (en) | Traditional Chinese medicine composition for treating optic atrophy | |
| CN104689092A (en) | Medicine for treating stroke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: CHANGCHUN QINGXI SHIJIE MEDICAL INTRUMENT CO., LTD Free format text: FORMER OWNER: LIU KE Effective date: 20150429 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150429 Address after: 6 building, 46 pharmaceutical building, 130000 Shengli Road, Kuancheng District, Jilin, Changchun Patentee after: Changchun clear vision Medical Instrument Co., Ltd. Address before: 130000, Changchun City, Jilin Province, Hangzhou Road, sun century, 7, 1 door, room 142 Patentee before: Liu Ke |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131120 Termination date: 20210516 |